Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis.
White P. et al, (2023), Journal of neurology, neurosurgery, and psychiatry
Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
Vanderven HA. et al, (2023), JCI Insight
Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.
McCann N. et al, (2023), BMJ open, 13
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Goldswain H. et al, (2023), Genome biology, 24
Malaria patient spectrum representation in therapeutic clinical trials of uncomplicated malaria: a scoping review of the literature.
Arena L. et al, (2023), Malaria journal, 22
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402
Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study.
Vink E. et al, (2022), Open forum infectious diseases, 9
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
Mentzer AJ. et al, (2022), Nature Medicine
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.
Siggins MK. et al, (2022), Immunology
Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737
Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever
Salerno-Gonçalves R. et al, (2022), Cellular Immunology, 378
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
Närhi F. et al, (2022), The Lancet Digital Health, 4, e220 - e234
Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Leclerc QJ. et al, (2021), BMC Health Services Research, 21
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial
Fisher BA. et al, (2021), The Lancet Respiratory Medicine
de Silva TI. et al, (2021), iScience, 24, 103353 - 103353
Wickenhagen A. et al, (2021), Science, 374